Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Test Tube Method Screens for Variant Hemoglobin

By LabMedica International staff writers
Posted on 14 Dec 2011
A ready-to-use test tube method for Hemoglobin E (HbE) has been described that can be employed as a screening test kit. More...


The novel test-tube method for HbE screening uses diethyl aminoethyl (DEAE)-cellulose resin and it is based on the principle of anion-exchange liquid chromatography.

Scientists at Chiang Mai University (Thailand) used the principle where DEAE-cellulose resin was used as the stationary phase, and glycine buffer with sodium chloride as the mobile phase. However, the method was set to be completed inside the tube instead of in an open-ended column. Equilibrated DEAE-cellulose resin is added to polystyrene tubes, followed by the addition of 2 mL eluting buffer. The tubes are capped and stored at 4 °C.

For HbE screen, packed red blood cells are mixed with a hemolysis reagent to obtain the hemolysate. An aliquot of hemolysate is added to the tube containing DEAE-cellulose resin suspension in eluting buffer, mixed vigorously and centrifuged. The color of the supernatant was then visualized after centrifugation. If the color of the supernatant was red, the result was positive, whereas a colorless or markedly pale red supernatant was negative. A positive result indicated the presence of HbE, while a negative result suggested the absence of HbE in the blood samples.

One hundred and thirteen blood samples were screened for HbE by the test tube method and by standard cellulose acetate electrophoresis (CAE). Seven of 113 samples were found to be positive for HbE by the tube method, in complete agreement with the findings from the CAE. The test-tube method is cheap and simple with no requirement of sophisticated equipment. The reagent could be stored at 4 °C for up to five months. Hemolysate samples aged up to five months were still suitable for this test.

HbE is a β-structural variant common worldwide. This Hb disorder can form a compound heterozygous state with the β-thalassemia gene, leading to life-threatening hereditary hemolytic anemia, HbE/β-thalassemia. The authors concluded that the novel test-tube method using the DEAE-cellulose resin (Sigma-Aldrich, Saint Louis, MO, USA) could be an alternative method of mass population screening for HbE, particularly in small health care facilities. The study was published online on August 23, 2011, in the International Journal of Laboratory Hematology.

Related Links:
Chiang Mai University
Sigma-Aldrich


Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Collection and Transport System
PurSafe Plus®
New
Automatic Chemiluminescence Immunoassay Analyzer
Shine i2000
New
Gel Cards
DG Gel Cards
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Left is the original cell image and right is same cell image zoomed in and rendered in the special imaging software (Photo courtesy of FIU)

Brain Inflammation Biomarker Detects Alzheimer’s Years Before Symptoms Appear

Alzheimer’s disease affects millions globally, but patients are often diagnosed only after memory loss and other symptoms appear, when brain damage is already extensive. Detecting the disease much earlier... Read more

Immunology

view channel
Image: The VENTANA HER2 (4B5) test is now CE-IVDR approved (Photo courtesy of Roche)

Companion Diagnostic Test Identifies HER2-Ultralow Breast Cancer and Biliary Tract Cancer Patients

Breast cancer is the most common cancer in Europe, with more than 564,000 new cases and 145,000 deaths annually. Metastatic breast cancer is rising in younger populations and remains the leading cause... Read more

Pathology

view channel
Image: An adult fibrosarcoma case report has shown the importance of early diagnosis and targeted therapy (Photo courtesy of Sultana and Sailaja/Oncoscience)

Accurate Pathological Analysis Improves Treatment Outcomes for Adult Fibrosarcoma

Adult fibrosarcoma is a rare and highly aggressive malignancy that develops in connective tissue and often affects the limbs, trunk, or head and neck region. Diagnosis is complex because tumors can mimic... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.